https://www.selleckchem.com/pr....oducts/hmpl-504-azd6
To assess the diagnostic performance of breast magnetic resonance (MR) imaging as a function of gadolinium contrast dose using a retrospective reader study. IRB approval was obtained prior to the start of this study and was HIPAA compliant. One-hundred and fifty MR breast examinations were included that were acquired between January 2001 and December 2006. Seventy-five patients received contrast doses (gadopentetate dimeglumine) by weight of 0.10mmol/kg and 75 patients were imaged using fixed volumes of 20ml. The imag
Gefällt mir
Kommentar
Teilen
